In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Jeff Stevens and David Shisel, co-founders of Psyched Wellness, the first publicly traded company in North America to bring an Amanita muscaria extract to market.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-330/?ref=278
Together, they discuss the mushroom's unique pharmacology, Psyched Wellness' multi-year path through Health Canada's safety testing, and the broader implications for the future of functional fungi. Paul also explores the tension between innovation and regulation, as Jeff and David share insights from operating in the gray area between supplements and psychedelics.
Jeff Stevens and David Shisel are the co-founders of Psyched Wellness. With backgrounds spanning capital markets, legal compliance, and product development, they've led the effort to bring Amanita muscaria into mainstream wellness through rigorous science and education.
Highlights:
- Understanding Amanita muscaria's active compounds
- Why Health Canada approval took three years
- How Psyched Wellness rebranded a controversial mushroom
- What separates Amanita from psilocybin
- Legal gray zones and ethical entrepreneurship
- Microdosing Amanita: early findings and consumer safety
- Building trust through transparency and research
Episode Links:
Episode Sponsors:
- The Practitioner Certification Program by Third Wave's Psychedelic Coaching Institute.
- The Microdosing Practitioner Certification by Third Wave's Psychedelic Coaching Institute helps you master Paul F. Austin's microdosing protocol and build a meaningful, profitable coaching practice in just 4 months. Early Bird pricing ends November 23. Program begins January 6, 2026.
